Nestlé Sells Peanut Allergy Drug, Ending the Food Giant’s Foray Into Biotech
MedCity News
SEPTEMBER 5, 2023
Palforzia was the first FDA-approved drug for peanut allergy, but its sales were hampered by the Covid-19 pandemic. Peanut allergy therapy Palforzia, which Nestlé acquired in a multi-billion dollar deal, has been sold to allergy product company Stallergenes Greer.
Let's personalize your content